Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1993 Oct;94(1):145–149. doi: 10.1111/j.1365-2249.1993.tb05992.x

The effects of cytokines on metalloproteinase inhibitors (TIMP) and collagenase production by human chondrocytes and TIMP production by synovial cells and endothelial cells.

M Shingu 1, Y Nagai 1, T Isayama 1, T Naono 1, M Nobunaga 1, Y Nagai 1
PMCID: PMC1534355  PMID: 8403497

Abstract

It has been suggested that IL-1 produces cartilage matrix degradation by metalloproteinases such as collagenase, and that such degradation is regulated by metalloproteinase inhibitors (TIMP). Therefore, the balance between collagenase and TIMP is an important factor for tissue destruction in inflammatory joints. In the present study the effects of cytokines on collagenase and TIMP production in chondrocytes as well as the effects of cytokines on TIMP production in connective tissue cells were studied. IL-1 beta inhibited TIMP production in endothelial cells while enhancing TIMP production in synovial cells and chondrocytes. In addition, tumour necrosis factor-alpha (TNF-alpha) significantly inhibited and IL-6 significantly enhanced TIMP production in endothelial cells, synovial cells and chondrocytes. In the chondrocyte supernatant, collagenase activity/TIMP ratio was significantly elevated by the addition of either IL-1 beta or TNF-alpha to the cells, whereas the ratio was significantly decreased by IL-6. These results suggest that the cytokine effects on TIMP production are different among the different cell types, and that either IL-1 beta or TNF-alpha induce cartilage matrix degradation by disrupting the collagenase/TIMP balance, while, on the other hand, IL-6 protects the tissue through an opposite effect.

Full text

PDF
145

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boone T. C., Johnson M. J., De Clerck Y. A., Langley K. E. cDNA cloning and expression of a metalloproteinase inhibitor related to tissue inhibitor of metalloproteinases. Proc Natl Acad Sci U S A. 1990 Apr;87(7):2800–2804. doi: 10.1073/pnas.87.7.2800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cambray G. J., Murphy G., Page-Thomas D. P., Reynolds J. J. The production in culture of metalloproteinases and an inhibitor by joint tissues from normal rabbits, and from rabbits with a model arthritis. I. Synovium. Rheumatol Int. 1981;1(1):11–16. doi: 10.1007/BF00541217. [DOI] [PubMed] [Google Scholar]
  3. Cawston T. E., Galloway W. A., Mercer E., Murphy G., Reynolds J. J. Purification of rabbit bone inhibitor of collagenase. Biochem J. 1981 Apr 1;195(1):159–165. doi: 10.1042/bj1950159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dayer J. M., de Rochemonteix B., Burrus B., Demczuk S., Dinarello C. A. Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells. J Clin Invest. 1986 Feb;77(2):645–648. doi: 10.1172/JCI112350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dean D. D., Martel-Pelletier J., Pelletier J. P., Howell D. S., Woessner J. F., Jr Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest. 1989 Aug;84(2):678–685. doi: 10.1172/JCI114215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hirano T., Taga T., Nakano N., Yasukawa K., Kashiwamura S., Shimizu K., Nakajima K., Pyun K. H., Kishimoto T. Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). Proc Natl Acad Sci U S A. 1985 Aug;82(16):5490–5494. doi: 10.1073/pnas.82.16.5490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Houston J. P., McGuire M. K., Meats J. E., Ebsworth N. M., Russell R. G., Crawford A., Mac Neil S. Adenylate cyclase of human articular chondrocytes. Responsiveness to prostaglandins and other hormones. Biochem J. 1982 Oct 15;208(1):35–42. doi: 10.1042/bj2080035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kobayashi I., Ziff M. Electron microscopic studies of the cartilage-pannus junction in rheumatoid arthritis. Arthritis Rheum. 1975 Sep-Oct;18(5):475–483. doi: 10.1002/art.1780180507. [DOI] [PubMed] [Google Scholar]
  9. Kodama S., Kishi J., Obata K., Iwata K., Hayakawa T. Monoclonal antibodies to bovine collagenase inhibitor. Coll Relat Res. 1987 Oct;7(5):341–350. doi: 10.1016/s0174-173x(87)80027-4. [DOI] [PubMed] [Google Scholar]
  10. Kodama S., Yamashita K., Kishi J., Iwata K., Hayakawa T. A sandwich enzyme immunoassay for collagenase inhibitor using monoclonal antibodies. Matrix. 1989 Jan;9(1):1–6. doi: 10.1016/s0934-8832(89)80011-3. [DOI] [PubMed] [Google Scholar]
  11. McGuire M. B., Murphy G., Reynolds J. J., Russell R. G. Production of collagenase and inhibitor (TIMP) by normal, rheumatoid and osteoarthritic synovium in vitro: effects of hydrocortisone and indomethacin. Clin Sci (Lond) 1981 Dec;61(6):703–710. doi: 10.1042/cs0610703. [DOI] [PubMed] [Google Scholar]
  12. Mignatti P., Tsuboi R., Robbins E., Rifkin D. B. In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases. J Cell Biol. 1989 Feb;108(2):671–682. doi: 10.1083/jcb.108.2.671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Murphy G., Cartwright E. C., Sellers A., Reynolds J. J. The detection and characterisation of collagenase inhibitors from rabbit tissues in culture. Biochim Biophys Acta. 1977 Aug 11;483(2):493–498. doi: 10.1016/0005-2744(77)90080-8. [DOI] [PubMed] [Google Scholar]
  14. Pelletier J. P., Mineau F., Faure M. P., Martel-Pelletier J. Imbalance between the mechanisms of activation and inhibition of metalloproteases in the early lesions of experimental osteoarthritis. Arthritis Rheum. 1990 Oct;33(10):1466–1476. doi: 10.1002/art.1780331003. [DOI] [PubMed] [Google Scholar]
  15. Sato T., Ito A., Mori Y. Interleukin 6 enhances the production of tissue inhibitor of metalloproteinases (TIMP) but not that of matrix metalloproteinases by human fibroblasts. Biochem Biophys Res Commun. 1990 Jul 31;170(2):824–829. doi: 10.1016/0006-291x(90)92165-v. [DOI] [PubMed] [Google Scholar]
  16. Shingu M., Hashimoto Y., Johnson A. R., Hurd E. R. The search for Fc receptors on human tissues and human endothelial cells in culture. Proc Soc Exp Biol Med. 1981 Jun;167(2):147–155. doi: 10.3181/00379727-167-41140. [DOI] [PubMed] [Google Scholar]
  17. Tawara T., Shingu M., Nobunaga M., Naono T. Effects of recombinant human IL-1 beta on production of prostaglandin E2, leukotriene B4, NAG, and superoxide by human synovial cells and chondrocytes. Inflammation. 1991 Apr;15(2):145–157. doi: 10.1007/BF00917509. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES